Generation Bio is a biotechnology company in the healthcare sector on NASDAQ, led by Geoff McDonough, with a market cap of $36.6M. As of Q3 2025, 59% of shares are held by 37 institutional investors, with Atlas Venture Life Science Advisors, LLC as the largest holder at 12.29%.
Overview of institutional ownership in GBIO as of Q3 2025 with a market cap of $41.2M
Based on market cap of $41.2M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in GBIO as of Q3 2025
| Institution | Position Value |
|---|---|
A Atlas Venture Life Science Advisors, LLC Institution | $5.1M 0.67% of portfolio |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $3.5M 0.00% of portfolio |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $2.1M 0.00% of portfolio |
S Siren, L.L.C. Institution | $1.8M 0.08% of portfolio |
VANGUARD GROUP INC Institution | $1.4M 0.00% of portfolio |
Marshall Wace LLP Institution | $1.3M 0.00% of portfolio |
B BAKER BROS. ADVISORS LP Hedge Fund•Sector | $1.2M 0.01% of portfolio |
MORGAN STANLEY RIA/Wealth | $1.0M 0.00% of portfolio |
UBS Group AG Institution | $910.2K 0.00% of portfolio |
ACADIAN ASSET MANAGEMENT LLC Long Only Manager | $780.3K 0.00% of portfolio |
Institutional buying and selling activity for GBIO in Q3 2025
| Institution | Net Bought |
|---|---|
Marshall Wace LLP Institution | +$1.3M +218.5K shares |
C CANTOR FITZGERALD, L. P. Institution | +$605.9K +99.0K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | +$527.5K +86.2K shares |
MORGAN STANLEY RIA/Wealth | +$446.7K +73.0K shares |
UBS Group AG Institution | +$368.6K +60.2K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$171.2K +28.0K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | +$135.5K +22.1K shares |
FMR LLC Institution | +$79.8K +-221.5K shares |
GOLDMAN SACHS GROUP INC Institution | +$74.5K +12.2K shares |
X XTX Topco Ltd Institution | +$69.4K +11.3K shares |
| Institution | Net Sold |
|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | −$1.6M −269.5K shares |
B BlackRock, Inc. Institution | −$343.0K −56.0K shares |
Militia Capital Partners, LP Hedge Fund•Long/Short | −$173.6K −54.2K shares |
S Squarepoint Ops LLC Hedge Fund•Quant | −$165.9K −51.8K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | −$79.8K −24.9K shares |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC Long Only Manager | −$75.8K −23.7K shares |
TWO SIGMA ADVISERS, LLC Hedge Fund•Multi-Strategy | −$61.3K −19.1K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$53.9K −8.8K shares |
Y Y-Intercept Ltd Institution | −$47.4K −14.8K shares |
T TD ASSET MANAGEMENT INC Institution | −$45.0K −7.4K shares |
Institutions that initiated new positions or completely exited GBIO in Q3 2025
| Institution | Position Value |
|---|---|
C CANTOR FITZGERALD, L. P. Institution | $605.9K 99.0K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | $135.5K 22.1K shares |
S Shay Capital LLC Institution | $63.7K 10.4K shares |
Rockefeller Capital Management L.P. Long Only Manager | $2.1K 350.0 shares |
O Optiver Holding B.V. Institution | $31.0 5.0 shares |
| Institution | Previous Position |
|---|---|
Militia Capital Partners, LP Hedge Fund•Long/Short | $173.6K 54.2K shares |
S Squarepoint Ops LLC Hedge Fund•Quant | $165.9K 51.8K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $79.8K 24.9K shares |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC Long Only Manager | $75.8K 23.7K shares |
TWO SIGMA ADVISERS, LLC Hedge Fund•Multi-Strategy | $61.3K 19.1K shares |
Y Y-Intercept Ltd Institution | $47.4K 14.8K shares |
BARCLAYS PLC Institution | $36.8K 1.1K shares |
Aegis Wealth Management LLC RIA/Wealth | $36.0K 8.9K shares |
Callan Family Office, LLC Family Office | $22.3K 7.0K shares |
AQR CAPITAL MANAGEMENT LLC Hedge Fund•Multi-Strategy | $20.4K 6.4K shares |
Institutions with the largest Call and Put options positions in GBIO as of Q3 2025
| Institution | Position Value |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | - - contracts |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with GBIO as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
A Atlas Venture Life Science Advisors, LLC Institution | 0.67% $5.1M |
YIHENG CAPITAL LLC Hedge Fund•Long/Short | 0.22% $645.8K |
S Siren, L.L.C. Institution | 0.08% $1.8M |
P Palo Alto Investors, LLC Hedge Fund•Long/Short | 0.02% $92.1K |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | 0.01% $135.5K |
C CANTOR FITZGERALD, L. P. Institution | 0.01% $605.9K |
S Shay Capital LLC Institution | 0.01% $63.7K |
B BAKER BROS. ADVISORS LP Hedge Fund•Sector | 0.01% $1.2M |
X XTX Topco Ltd Institution | 0.00% $69.4K |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | 0.00% $2.1M |
Discover hedge funds investing in GBIO
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Unknown Unknown | $114.7M | 11.54% | |
Biotechnology Healthcare | $85.3M | 8.58% | |
Biotechnology Healthcare | $65.7M | 6.61% |
We use cookies for analytics. See our Privacy and Cookie Policy.